Anterix Inc. (ATEX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Sales | 6,501 | 6,031 | 4,191 | 1,919 | 1,084 |
| Cost of Goods | N/A | N/A | N/A | N/A | 5 |
| Gross Profit | 6,501 | 6,031 | 4,191 | 1,919 | 1,079 |
| Operating Expenses | -87,429 | 17,745 | 14,313 | 18,380 | 37,932 |
| Operating Income | 93,930 | -11,714 | -10,122 | -16,461 | -36,848 |
| Other Income | 1,776 | 2,234 | 2,607 | 1,406 | 312 |
| Pre-tax Income | 95,706 | -9,480 | -7,515 | -15,055 | -36,536 |
| Income Tax | 5,071 | 1,892 | 1,613 | 1,262 | 983 |
| Net Income Continuous | 90,635 | -11,372 | -9,128 | -16,317 | -37,519 |
| Net Income | $90,635 | $-11,372 | $-9,128 | $-16,317 | $-37,519 |
| EPS Basic Total Ops | 4.85 | -0.61 | -0.49 | -0.87 | -2.07 |
| EPS Basic Continuous Ops | 4.85 | -0.61 | -0.49 | -0.87 | -2.07 |
| EPS Diluted Total Ops | 4.83 | -0.61 | -0.49 | -0.87 | -2.07 |
| EPS Diluted Continuous Ops | 4.83 | -0.61 | -0.49 | -0.87 | -2.07 |
| EPS Diluted Before Non-Recurring Items | -1.08 | -2.36 | -0.49 | -2.33 | -2.07 |
| EBITDA(a) | $94,394 | $-11,166 | $-9,278 | $-15,041 | $-35,398 |